Lilly to Build $6.5B API Manufacturing Facility in Houston
Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, described as a next-generation...
Merck and Siemens to Accelerate AI Driven Drug Development
Merck and Siemens have expanded their collaboration by signing a new Memorandum of Understanding (MoU) aimed at advancing digital transformation in the life science...
ABPI Launches Manifesto to Advance Scottish Pharma Sector
The Association of the British Pharmaceutical Industry (ABPI) has released its manifesto for the Scottish Government, calling for political leaders to act now and...
Automating Experimental Design with Generative AI in Pharma
Automating Experimental Design with Generative AI in PharmaAutomating Experimental Design with Generative AI for Pharma Scientists
The pharmaceutical research landscape is experiencing a fundamental transformation...
Generative AI Bridging Wet Lab and Dry Lab Workflows
Bridging Wet Lab and Dry Lab Workflows with Generative AI Tools
The traditional division between computational "dry lab" research and experimental "wet lab" activities has...
GSK to Invest $30B in Drug Manufacturing and R&D in the US
GSK plc has unveiled a plan to invest $30 billion into research, development and supply chain infrastructure across the United States. The announcement includes...
US FDA Tightens Oversight on Misleading Drug Advertising
The U.S. Food and Drug Administration (FDA) announced that it will issue approximately 100 cease-and-desist enforcement notices alongside thousands of warning letters directed at...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...